Macular disease
‘We can’t stand back and watch macular disease patients experience preventable vision loss’
One of the country’s largest optometry networks has teamed up with Macular Disease Foundation Australia in an Australian-first, supporting nAMD...
Read more
Benefits of improving macular disease treatment persistence
May is Macula Month. To mark 2023’s awareness campaign Macular Disease Foundation Australia reveals new insights into the health and...
Read more
Iveric Bio reveals vision loss reduction data in investigational geographic atrophy therapy
US biopharmaceutical company Iveric Bio has released new data for its avacincaptad pegol (ACP) therapy for geographic atrophy (GA), which...
Read more
FDA approves Apellis’ SYFOVRE for first geographic atrophy treatment
In a historic first, the US Food and Drug Administration (FDA) has approved SYFOVRE (pegcetacoplan injection), manufactured by global biopharmaceutical...
Read more
Prof Robyn Guymer: Is Australia ready for the latest AMD therapies?
The treatment landscape for wet and dry AMD is undergoing a seismic shift in Australia. CERA’s head of macular research...
Read moreTGA registers Vabysmo to treat two primary causes of vision loss
Roche Australia has announced the Australian Therapeutic Goods Administration (TGA) has registered Vabysmo (faricimab) for the treatment of neovascular or...
Read moreNew anti-VEGF therapies seeking Aussie approval
The suppliers of two new anti-VEGF therapies recently cleared in the US that work to reduce macular disease treatment burdens...
Read more
FDA approves Susvimo continuous drug delivery implant for AMD
The US Food and Drug Administration (FDA) has approved the Susvimo implant which delivers ranibizumab continuously, offering patients living with...
Read more
Prof Robyn Guymer ‘thrilled’ by Phase 3 results of pegcetacoplan for dry AMD
Prominent Melbourne retinal disease researcher Professor Robyn Guymer is encouraged by the Phase 3 results of a trial she’s been...
Read more
Infrared light could replace injections for macular oedema
A clinical trial at Sydney Eye Hospital is evaluating the safety and efficacy of using infrared light to treat macular...
Read more